Screening for hepatitis C virus in human immunodeficiency virus-infected individuals

Journal of Clinical Microbiology

Volumn 38, Issue 2, 2000, Pages 575-577

  Thio, Chloe L ^a   Nolt, Karen R ^a   Astemborski, Jacquie ^b   Vlahov, David ^b,c   Nelson, Kenrad E ^b   Thomas, David L ^a,b,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; DNA DETERMINATION; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SCREENING; VIRUS DETECTION;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0033966433     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.2.575-577.2000     Document Type: Article

References (12)

1. Anonymous. 1997. National Institutes of Health consensus development conference panel statement: management of hepatitis C. Hepatology 26:2S-10S.
2. Biggar, R. J., J. J. Goedert, and J. Hoofnagle. 1987. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N. Engl. J. Med. 316:630-631.
3. Centers for Disease Control and Prevention. 1998. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbid. Mortal. Weekly Rep. 47:1-39.
4. Centers for Disease Control and Prevention. 1999. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with Human Immunodeficiency Virus: disease-specific recommendations. Morbid. Mortal. Weekly Rep. 48:1-82.
5. Chamot, E., B. Hirschel, J. Wintsch, C. F. Robert, V. Gabriel, J. J. Deglon, S. Yerly, and L. Perrin. 1990. Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS 4:1275-1277.
6. Eyster, M. E., L. S. Diamondstone, J. M. Lien, W. C. Ehmann, S. Quan, and J. J. Goedert. 1993. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J. Acquir. Immune Defic. Syndr. 6:602-610.
7. John, M., J. Flexman, and M. A. H. French. 1998 Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS 12:2289-2293.
8. Johnson, P. D. R., S. R. Graves, L. Stewart, R. Warren, B. Dwyer, and C. R. Lucas. 1991. Specific syphilis serological tests may become negative in HIV infection. AIDS 5:419-423.
9. Sorbi, D., D. Shen, and G. Lake-Bakaar. 1996. Influence of HIV disease on serum anti-HCV antibody titers: a study of intravenous drug users. J. Acquir. Immune Defic. Syndr. 13:295-296.
10. Thomas, D. L., J. W. Shih, H. J. Alter, D. Vlahov, S. Cohn, D. R. Hoover, L. Cheung, and K. E. Nelson. 1996. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J. Infect. Dis. 174:690-695.
11. Villano, S. A., D. Vlahov, K. E. Nelson, C. M. Lyles, S. Cohn, and D. L. Thomas. 1997. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J. Clin. Microbiol. 35:3274-3277.
12. Vlahov, D., J. C. Anthony, A. Muñoz, J. Margolik, D. D. Celentano, L. Solomon, and B. F. Polk. 1991. The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J. Drug Issues 21:759-776.